Industry Rep: Patients Need Non-Opioid Therapies For Chronic Pain

The chronic pain patient community argued that policies to lower opioid prescribing rates are having a negative effect on patients, speaking at an FDA meeting Monday (July 9). One industry representative acknowledged patients are feeling abandoned and anxious about the future of pain care, and added it is up to regulators, industry and health care providers to bring new options to market and to educate consumers about those options. FDA held the patient-focused drug development meeting to get chronic pain...